Venture Life Group PLC (LON:VLG) insider Carl Dempsey acquired 20,000 shares of the firm’s stock in a transaction that occurred on Thursday, July 11th. The shares were bought at an average cost of GBX 51 ($0.67) per share, with a total value of £10,200 ($13,328.11).

Shares of Venture Life Group stock opened at GBX 51.50 ($0.67) on Friday. The company has a current ratio of 3.03, a quick ratio of 2.43 and a debt-to-equity ratio of 22.03. Venture Life Group PLC has a 12 month low of GBX 36.75 ($0.48) and a 12 month high of GBX 55 ($0.72). The business’s fifty day moving average is GBX 46.18. The firm has a market capitalization of $43.11 million and a PE ratio of 128.75.

About Venture Life Group

Venture Life Group Plc develops and commercializes oral care products, food supplements, medical devices, and dermo-cosmetics for the ageing population in the United Kingdom, Europe, and internationally. It operates through Brands, and Development and Manufacturing segments. The company offers cardiovascular product for lowering cholesterol in food supplement; and neurology products, including NeuroAge, NeuroAge Sleep, and NeuroAge NRG food supplements to enhance mental alertness, cognitive function, and mental performance in ageing brain.

Read More: Hedge Funds

Receive News & Ratings for Venture Life Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Venture Life Group and related companies with MarketBeat.com's FREE daily email newsletter.